Mass cytometry: A highly multiplexed single-cell technology for advancing drug development

Drug Metabolism and Disposition

Volumn 43, Issue 2, 2015, Pages 227-233

  Atkuri, Kondala R ^a   Stevens, Jeffrey C ^a   Neubert, Hendrik ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL SURFACE RECEPTOR; LANTHANIDE; NEW DRUG; STABLE ISOTOPE; BIOLOGICAL MARKER;

ANTIBODY DETECTION; ANTIBODY LABELING; CELL FUNCTION; CYTOMETRY; DNA BARCODING; DRUG APPROVAL; DRUG DEVELOPMENT; DRUG INDUSTRY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; INTERNALIZATION; MASS CYTOMETRY; MASS SPECTROMETRY; PHARMACODYNAMICS; PHENOTYPE; REVIEW; SIGNAL PROCESSING; SINGLE CELL ANALYSIS; ANIMAL; ATOMIC ABSORPTION SPECTROMETRY; DEVICES; DRUG SCREENING; FLUORESCENT ANTIBODY TECHNIQUE; PHARMACOKINETICS; PROCEDURES; TRENDS;

ANIMALS; BIOMARKERS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; METALS, RARE EARTH; PHARMACOKINETICS; SINGLE-CELL ANALYSIS; SPECTROPHOTOMETRY, ATOMIC;

EID: 84919775675     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.114.060798     Document Type: Review

References (51)

1. Aghaeepour N, Jalali A, O'Neill K, Chattopadhyay PK, Roederer M, Hoos HH, and Brinkman RR (2012) RchyOptimyx: cellular hierarchy optimization for flow cytometry. Cytometry Part A 81:1022-1030.
2. Amir el-AD, Davis KL, Tadmor MD, Simonds EF, Levine JH, Bendall SC, Shenfeld DK, Krishnaswamy S, Nolan GP, and Pe'er D (2013) viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol 31:545-552.
3. Andreu EJ, Martin de Llano JJ, Moreno I, and Knecht E (1998) A rapid procedure suitable to assess quantitatively the endocytosis of colloidal gold and its conjugates in cultured cells. J Histochem Cytochem 46:1199-1201.
4. Bandura DR, Baranov VI, Ornatsky OI, Antonov A, Kinach R, Lou X, Pavlov S, Vorobiev S, Dick JE, and Tanner SD (2009) Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem 81:6813-6822.
5. Baranov VI, Quinn Z, Bandura DR, and Tanner SD (2002) A sensitive and quantitative elementtagged immunoassay with ICPMS detection. Anal Chem 74:1629-1636.
6. Behbehani GK, Bendall SC, Clutter MR, Fantl WJ, and Nolan GP (2012) Single-cell mass cytometry adapted to measurements of the cell cycle. Cytometry Part A 81:552-566.
7. Bendall SC, Simonds EF, Qiu P, Amir, el- AD, Krutzik PO, Finck R, Bruggner RV, Melamed R, Trejo A, and Ornatsky OI, et al. (2011) Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332:687-696.
8. Bodenmiller B, Zunder ER, Finck R, Chen TJ, Savig ES, Bruggner RV, Simonds EF, Bendall SC, Sachs K, and Krutzik PO, et al. (2012) Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol 30:858-867.
9. Bonilla L, Means G, Lee K, and Patterson S (2008) The evolution of tools for protein phosphorylation site analysis: from discovery to clinical application. Biotechniques 44: 671-679.
10. Brandwein JM, Hedley DW, Chow S, Schimmer AD, Yee KW, Schuh AC, Gupta V, Xu W, Kamel-Reid S, and Minden MD (2011) A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete response. Leukemia 25:945-952.
11. Chang RL, Yeh CH, and Albitar M (2010) Quantification of intracellular proteins and monitoring therapy using flow cytometry. Curr Drug Targets 11:994-999.
12. Chattopadhyay PK, Gierahn TM, Roederer M, and Love JC (2014) Single-cell technologies for monitoring immune systems. Nat Immunol 15:128-135.
13. Crump M, Hedley D, Kamel-Reid S, Leber B, Wells R, Brandwein J, Buckstein R, Kassis J, Minden M, and Matthews J, et al. (2010) A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study. Leuk Lymphoma 51:252-260.
14. Darzynkiewicz Z (2010) Critical aspects in analysis of cellular DNA content. Curr Protoc Cytom April:Chapter 7, Unit7.2.
15. Darzynkiewicz Z (2012) Cycling into future: mass cytometry for the cell-cycle analysis. Cytometry Part A 81:546-548.
16. Darzynkiewicz Z, Halicka HD, and Zhao H (2010) Analysis of cellular DNA content by flow and laser scanning cytometry. Adv Exp Med Biol 676:137-147.
17. De Rosa SC, Herzenberg LA, Herzenberg LA, and Roederer M (2001) 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 7:245-248.
18. Dieterlen MT, Eberhardt K, Tarnok A, Bittner HB, and Barten MJ (2011) Flow cytometrybased pharmacodynamic monitoring after organ transplantation. Methods Cell Biol 103: 267-284.
19. Ellinger B, Silber J, Prashar A, Landskron J, Weber J, Rehermann S, Müller FJ, Smith S, Wrigley S, and Taskén K, et al. (2014) A phenotypic screening approach to identify anticancer compounds derived from marine fungi. Assay Drug Dev Technol 12:162-175.
20. Finck R, Simonds EF, Jager A, Krishnaswamy S, Sachs K, Fantl W, Pe'er D, Nolan GP, and Bendall SC (2013) Normalization of mass cytometry data with bead standards. Cytometry Part A 83:483-494.
21. Guerrouahen BS, Wieder E, Blanchard EG, Lee FY, Aplenc R, and Corey SJ (2009) Flow cytometric determination of Src phosphorylation in pediatric patients treated with dasatinib. Pediatr Blood Cancer 53:1132-1135.
22. Guilliams M, Bruhns P, Saeys Y, Hammad H, and Lambrecht BN (2014) The function of Fcg receptors in dendritic cells and macrophages. Nat Rev Immunol 14:94-108.
23. Hale MB and Nolan GP (2006) Phospho-specific flow cytometry: intersection of immunology and biochemistry at the single-cell level. Curr Opin Mol Ther 8:215-224.
24. Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, Dekker CL, Mackey S, Maecker H, Swan GE, et al. (2013) Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med 5:208ra145.
25. Kantor AB (2002) Comprehensive phenotyping and biological marker discovery. Dis Markers 18:91-97.
26. Krutzik PO, Crane JM, Clutter MR, and Nolan GP (2008) High-content single-cell drug screening with phosphospecific flow cytometry. Nat Chem Biol 4:132-142.
27. Krutzik PO, Clutter MR, Trejo A, and Nolan GP (2011) Fluorescent cell barcoding for multiplex flow cytometry. Curr Prot January:Chapter 6, Unit 6.31.
28. Lappin PB and Black LE (2003) Immune modulator studies in primates: the utility of flow cytometry and immunohistochemistry in the identification and characterization of immunotoxicity. Toxicol Pathol 31 (Suppl):111-118.
29. Lim SM, Hwang JW, Bae SK, Bae SH, Ahn JB, Rha SY, Roh JK, Chung HC, and Shin SJ (2012) Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phosphospecific flow cytometry. Anal Quant Cytopathol Histpathol 34:309-316.
30. Maecker HT (2009) Multiparameter flow cytometry monitoring of T cell responses. Methods Mol Biol 485:375-391.
31. McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, Altman JD, Nixon DF, Ottinger J, Li J, and Beckett L et al. (2008a) Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms. Cytometry Part A 73:411-420.
32. McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, Altman JD, Nixon DF, Ottinger J, Oxford C, Evans TG, and Asmuth DM (2008b) Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach. Cytometry Part A 73:400-410.
33. Newell EW, Sigal N, Bendall SC, Nolan GP, and Davis MM (2012) Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36:142-152.
34. Nimmerjahn F and Ravetch JV (2006) Fcgamma receptors: old friends and new family members. Immunity 24:19-28.
35. Nolan JP, Lauer S, Prossnitz ER, and Sklar LA (1999) Flow cytometry: a versatile tool for all phases of drug discovery. Drug Discov Today 4:173-180.
36. Ornatsky O, Baranov VI, Bandura DR, Tanner SD, and Dick J (2006) Multiple cellular antigen detection by ICP-MS. J Immunol Methods 308:68-76.
37. Ornatsky OI, Kinach R, Bandura DR, Lou X, Tanner SD, Baranov VI, Nitz M, and Winnik MA (2008a) Development of analytical methods for multiplex bio-assay with inductively coupled plasma mass spectrometry. J Anal At Spectrom 23:463-469.
38. Ornatsky OI, Lou X, Nitz M, Schäfer S, Sheldrick WS, Baranov VI, Bandura DR, and Tanner SD (2008b) Study of cell antigens and intracellular DNA by identification of element-containing labels and metallointercalators using inductively coupled plasma mass spectrometry. Anal Chem 80:2539-2547.
39. Ornatsky O, Bandura D, Baranov V, Nitz M, Winnik MA, and Tanner S (2010) Highly multiparametric analysis by mass cytometry. J Immunol Methods 361:1-20.
40. Pallis M, Abdul-Aziz A, Burrows F, Seedhouse C, Grundy M, and Russell N (2012) The multikinase inhibitor TG02 overcomes signalling activation by survival factors to deplete MCL1 and XIAP and induce cell death in primary acute myeloid leukaemia cells. Br J Haematol 159: 191-203.
41. Perez OD and Nolan GP (2006) Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol Rev 210:208-228.
42. Powers JJ, Dubovsky JA, Epling-Burnette PK, Moscinski L, Zhang L, Mustjoki S, Sotomayor EM, and Pinilla-Ibarz JA (2011) A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. Leuk Lymphoma 52:668-679.
43. Qiu P, Simonds EF, Bendall SC, Gibbs KD, Jr, Bruggner RV, Linderman MD, Sachs K, Nolan GP, and Plevritis SK (2011) Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol 29:886-891.
44. Roederer M, Brenchley JM, Betts MR, and De Rosa SC (2004) Flow cytometric analysis of vaccine responses: how many colors are enough? Clin Immunol 110:199-205.
45. Strumberg D, Richly H, Hilger RA, Schleucher N, Korfee S, Tewes M, Faghih M, Brendel E, Voliotis D, and Haase CG, et al. (2005) Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. J Clin Oncol 23:965-972.
46. Tanner SD, Baranov VI, Ornatsky OI, Bandura DR, and George TC (2013) An introduction to mass cytometry: fundamentals and applications. Cancer Immunol Immunother 62:955-965.
47. Tinhofer I, Hristozova T, Stromberger C, Keilhoiz U, and Budach V (2012) Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 83:e685-e690.
48. Vafadari R, Weimar W, and Baan CC (2012) Phosphospecific flow cytometry for pharmacodynamic drug monitoring: analysis of the JAK-STAT signaling pathway. Clin Chim Acta 413: 1398-1405.
49. Wang L, Abbasi F, Omatsky O, Cole KD, Misakian M, Graigalas AK, He HJ, Marti GE, Tanner S, and Stebbings R (2012) Human CD4+ lymphocytes for antigen quantification: Characterization using conventional flow cytometry and mass cytometry. Cytometry A 81:567-575.
50. Wong KL, Yeap WH, Tai JJ, Ong SM, Dang TM, and Wong SC (2012) The three human monocyte subsets: implications for health and disease. Immunol Res 53:41-57.
51. Zhang J, Yang PL, and Gray NS (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9:28-39.